References
- Farrell JJ. Prevalence, diagnosis and management of pancreatic cystic neoplasms: current status and future directions. Gut Liver 2015;9:571-589. https://doi.org/10.5009/gnl15063
- Lee KS, Sekhar A, Rofsky NM, Pedrosa I. Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am J Gastroenterol 2010;105:2079-2084. https://doi.org/10.1038/ajg.2010.122
- Crippa S, Fernandez-Del Castillo C, Salvia R, et al. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol 2010;8:213-219. https://doi.org/10.1016/j.cgh.2009.10.001
- Jang JY, Kim SW, Lee SE, et al. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Ann Surg Oncol 2008;15:199-205. https://doi.org/10.1245/s10434-007-9603-5
- Nagai K, Doi R, Ito T, et al. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Surg 2009;16:353-358. https://doi.org/10.1007/s00534-009-0068-8
- Salvia R, Fernandez-del Castillo C, Bassi C, et al. Mainduct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004;239:678-685; discussion 685-687. https://doi.org/10.1097/01.sla.0000124386.54496.15
- Kim TH, Song TJ, Lee SO, et al. Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: duct diameter of less than 10 mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery. Pancreatology 2019;19:1054-1060. https://doi.org/10.1016/j.pan.2019.09.010
- Abdeljawad K, Vemulapalli KC, Schmidt CM, et al. Prevalence of malignancy in patients with pure main duct intraductal papillary mucinous neoplasms. Gastrointest Endosc 2014;79:623-629. https://doi.org/10.1016/j.gie.2013.08.024
- Crippa S, Bassi C, Salvia R, et al. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing nonoperative management: a mid-term follow-up analysis. Gut 2017;66:495-506. https://doi.org/10.1136/gutjnl-2015-310162
- Goh BK, Tan YM, Chung YF, et al. A review of mucinous cystic neoplasms of the pancreas defined by ovarian-type stroma: clinicopathological features of 344 patients. World J Surg 2006;30:2236-2245. https://doi.org/10.1007/s00268-006-0126-1
- Park JW, Jang JY, Kang MJ, Kwon W, Chang YR, Kim SW. Mucinous cystic neoplasm of the pancreas: is surgical resection recommended for all surgically fit patients? Pancreatology 2014;14:131-136. https://doi.org/10.1016/j.pan.2013.12.006
- Tanaka M, Fernandez-Del Castillo C, Kamisawa T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 2017;17:738-753. https://doi.org/10.1016/j.pan.2017.07.007
- European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut 2018;67:789-804. https://doi.org/10.1136/gutjnl-2018-316027
- Ohtsuka T, Matsunaga T, Kimura H, et al. Role of pancreatic juice cytology in the preoperative management of intraductal papillary mucinous neoplasm of the pancreas in the era of international consensus guidelines 2012. World J Surg 2014;38:2994-3001. https://doi.org/10.1007/s00268-014-2684-y
- Aso T, Ohtsuka T, Matsunaga T, et al. "High-risk stigmata" of the 2012 international consensus guidelines correlate with the malignant grade of branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2014;43:1239-1243. https://doi.org/10.1097/MPA.0000000000000199
- Kanno A, Satoh K, Hirota M, et al. Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas. J Gastroenterol 2010;45:952-959. https://doi.org/10.1007/s00535-010-0238-0
- Rodriguez JR, Salvia R, Crippa S, et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 2007;133:72-79; quiz 309-310. https://doi.org/10.1053/j.gastro.2007.05.010
- Kim TH, Woo YS, Chon HK, et al. Predictors of malignancy in "pure" branch-duct intraductal papillary mucinous neoplasm of the pancreas without enhancing mural nodules on CT imaging: a nationwide multicenter study. Gut Liver 2018;12:583-590. https://doi.org/10.5009/gnl17582
- Jung W, Park T, Kim Y, et al. Validation of a nomogram to predict the risk of cancer in patients with intraductal papillary mucinous neoplasm and main duct dilatation of 10mm or less. Br J Surg 2019;106:1829-1836. https://doi.org/10.1002/bjs.11293
- Pergolini I, Sahora K, Ferrone CR, et al. Long-term risk of pancreatic malignancy in patients with branch duct intraductal papillary mucinous neoplasm in a referral center. Gastroenterology 2017;153:1284-1294.e1. https://doi.org/10.1053/j.gastro.2017.07.019
- Lawrence SA, Attiyeh MA, Seier K, et al. Should patients with cystic lesions of the pancreas undergo long-term radiographic surveillance?: results of 3024 patients evaluated at a single institution. Ann Surg 2017;266:536-544. https://doi.org/10.1097/SLA.0000000000002371
- Crippa S, Pezzilli R, Bissolati M, et al. Active surveillance beyond 5 years is required for presumed branchduct intraductal papillary mucinous neoplasms undergoing non-operative management. Am J Gastroenterol 2017;112:1153-1161. https://doi.org/10.1038/ajg.2017.43
- Mukewar S, de Pretis N, Aryal-Khanal A, et al. Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms. Gut 2017;66:1811-1817. https://doi.org/10.1136/gutjnl-2016-311615
- Oyama H, Tada M, Takagi K, et al. Long-term risk of malignancy in branch-duct intraductal papillary mucinous neoplasms. Gastroenterology 2020;158:226-237.e5. https://doi.org/10.1053/j.gastro.2019.08.032
- Choi SH, Park SH, Kim KW, Lee JY, Lee SS. Progression of unresected intraductal papillary mucinous neoplasms of the pancreas to cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2017;15:1509-1520.e4. https://doi.org/10.1016/j.cgh.2017.03.020
- Salvia R, Castillo CF, Bassi C, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004;239:678-687. https://doi.org/10.1097/01.sla.0000124386.54496.15
- Suzuki Y, Atomi Y, Sugiyama M, et al. Cystic neoplasm of the pancreas: a Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas 2004;28:241-246. https://doi.org/10.1097/00006676-200404000-00005
- Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification. J Clin Gastroenterol 2006;40:856-862. https://doi.org/10.1097/01.mcg.0000225609.63975.6f
- Schmidt CM, White PB, Waters JA, et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg 2007;246:644-651; discussion 651-654. https://doi.org/10.1097/SLA.0b013e318155a9e5
- Ceppa EP, Roch AM, Cioffi JL, et al. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm. Surgery 2015;158:937-944; discussion 944-945. https://doi.org/10.1016/j.surg.2015.06.003
- Sahora K, Fernandez-del Castillo C, Dong F, et al. Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct. Surgery 2014;156:611-621. https://doi.org/10.1016/j.surg.2014.04.023
- Crippa S, Pergolini I, Rubini C, et al. Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/mainduct intraductal papillary mucinous neoplasms. Surgery 2016;159:1041-1049. https://doi.org/10.1016/j.surg.2015.11.003
- Hackert T, Fritz S, Klauss M, et al. Main-duct intraductal papillary mucinous neoplasm: high cancer risk in duct diameter of 5 to 9 mm. Ann Surg 2015;262:875-880; discussion 880-881. https://doi.org/10.1097/SLA.0000000000001462
- Vanella G, Crippa S, Archibugi L, et al. Meta-analysis of mortality in patients with high-risk intraductal papillary mucinous neoplasms under observation. Br J Surg 2018;105:328-338. https://doi.org/10.1002/bjs.10768